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Vitamin B6 is an essential nutrient in the human diet. It can act as a co-enzyme for numerous metabolic enzymes and has recently been shown to be a potent antioxidant. Plants and microorganisms have the ability to make the compound. Yet, studies of vitamin B6 biosynthesis have been mainly restricted to Escherichia coli, where the vitamin is synthesized from 1-deoxy-D-xylulose 5-phosphate and 4-phosphohydroxy-L-threonine. Recently, a novel pathway for its synthesis has been discovered, involving two genes (PDX1 and PDX2) neither of which is homologous to any of those participating in the E. coli pathway. In Bacillus subtilis, YaaD and YaaE represent the PDX1 and PDX2 homolog, respectively. The two proteins form a complex that functions as a glutamine amidotransferase, with YaaE as the glutaminase domain and YaaD as the acceptor and pyridoxal 5-phosphate (PLP) synthesis domain. In this report we corroborate a recent report on the identification of the substrates of YaaD and provide unequivocal proof of the identity of the reaction product. We show that both the glutaminase and synthase reactions are dependent on the respective protein partner. The synthase reaction can also utilize an external ammonium source but, in contrast to other glutamine amidotransferases, is dependent on YaaE under certain conditions. Furthermore, we report on the detailed characterization of the inhibition of the glutaminase domain, and thus PLP synthesis, by the glutamine analog acivicin. Employing pull-out assays and native-PAGE, we provide evidence for the dissociation of the bi-enzyme complex under these conditions. The results are discussed in light of the nature of the interaction of the two components of the enzyme complex.
In humans vitamin B6 is required for the maintenance of health. From a biochemical point of view the vitamin is well recognized in its active form as pyridoxal 5Ј-phosphate (PLP), 2 one of nature's most versatile cofactors and required for many diverse enzymes ranging from amino acid metabolism to the biosynthesis of antibiotic compounds. Furthermore, very recently, the B6 vitamers have been shown to be potent antioxidants equivalent to vitamins C and E, effectively quenching the reactive oxygen species singlet oxygen and superoxide anion in vitro (1, 2) . Vitamin B6 is synthesized in bacteria, fungi, and plants; yet, despite its essential role, its biosynthesis has been studied at the enzymatic level essentially only in the Gram-negative bacterium Escherichia coli (3) (4) (5) (6) (7) where it is derived from D-erythrose-4-phosphate, deoxy-Dxylulose 5-phosphate, and glutamate (5, 8 -10 ) (Scheme 1). The biosynthesis of the vitamin has recently come back into scrutiny, because it has become clear from studies in fungi that a pathway different from that in E. coli exists (1, (11) (12) (13) (14) .
Two of the key genes involved in this novel pathway have been identified (PDX1 and PDX2) (1, (15) (16) (17) , neither of which show similarity to any of the E. coli genes (1, 15, 16) . At the outset, amino acid sequence alignment studies indicated that PDX2 was likely to be the glutaminase domain of a class 1 glutamine amidotransferase (11, 18) , which displays the signature catalytic triad Cys-His-Glu (19) . This has been substantiated recently by the availability of the three-dimensional structure of the Bacillus subtilis PDX2 protein (YaaE), although in the absence of ligands (20) . Moreover, 15 N-labeling studies in yeast had indicated that the nitrogen atom of pyridoxine is derived from the amide moiety of glutamine (9, 10) , whereas in the E. coli pathway it is derived from glutamate (10, 21) . Indeed, glutaminase activity has since been demonstrated for the PDX2 proteins of B. subtilis, Saccharomyces cerevisiae, and Plasmodium falciparum (22) (23) (24) , designated YaaE (PdxT), SNO1, and PDX2, respectively. However, glutaminase activity was only observed in the presence of PDX1, which was shown to co-purify with PDX2, forming a hetero-oligomeric complex as has been observed for other glutamine amidotransferases (22, 23) . In general, glutamine amidotransferases consist of two domains, a glutaminase domain, which hydrolyzes glutamine to glutamate and ammonia, and a synthase domain that accepts and utilizes the ammonia from the glutaminase domain (19) . It was, therefore, postulated that PDX1 is likely to be the synthase subunit of the glutamine amidotransferase hetero-oligomeric complex (22) (23) (24) , but the nature of the substrates in the synthase reaction remained unknown. Nonetheless, extensive labeling studies in yeast had established that the origin of the C5-chain C-2Ј,2,3,4,4Ј of pyridoxamine is derived from an intact glucose-derived pentulose and/or pentose intermediate rather than deoxy-D-xylulose s-phosphate as in E. coli (25) , and more recently a genetic study in yeast indicated that the five-carbon sugar might be ribulose 5-phosphate (26) , but the identity of the remaining triose sugar remained elusive (12) . While this report was in preparation, enzymatic synthesis of vitamin B6 was demonstrated (27) using either of the C5 sugars, ribose 5-phosphate or ribulose 5-phosphate, and either of the C3 sugars, glyceraldehyde 3-phosphate or dihydroxyacetone phosphate, in the presence of glutamine and the PDX1 and PDX2 homologs from B. subtilis (YaaD and YaaE, respectively), but sufficient proof of the identity of the reaction product was not provided.
We have independently been able to reconstitute vitamin B6 biosynthesis with the B. subtilis proteins and herein report on the identity of the reaction product as pyridoxal 5Ј-phosphate. A detailed biochemical characterization of the B. subtilis YaaD and YaaE proteins in their native form is described, which shows that both the glutaminase and synthase activities are dependent on the respective protein partner when the physiological nitrogen donor glutamine is utilized. Vitamin B6 synthesis can be accomplished in vitro with an alternative source of ammonia.
However, when ribulose 5-phosphate is used as the C5 sugar under these conditions, the reaction is dependent on YaaE. Furthermore, an in depth characterization of the inhibition of the glutaminase subunit and thus PLP synthesis by the naturally occurring antimicrobial compound acivicin ((␣S,5S)-␣-amino-3-chloro-4,5-dihydro-5-isoxazole acetic acid) (28), a heterocyclic analog of glutamine, is provided. Most significantly, we show that in the presence of the inhibitor YaaD is no longer associated with YaaE. The nature of the interaction of YaaD and YaaE is discussed in light of the findings.
EXPERIMENTAL PROCEDURES
Materials-Acivicin and bovine liver glutamate dehydrogenase were purchased from Sigma; sinapic acid, ␣-cyano-4-hydroxycinnamic acid, and sequencing grade-modified trypsin were from Promega.
Cloning and Expression of B. subtilis YaaD/YaaE-The DNA sequence of the YaaD and YaaE genes of B. subtilis strain 168 were obtained from SubtiList (genolist.pasteur.fr/SubtiList/). Genomic DNA was isolated from B. subtilis strain 168 as described previously (29) . The YaaD and YaaE genes were amplified by PCR (YaaD: 5Ј-primer, CAT-GCCATGGCTCAAACAGGTACTGAACG, 3Ј-primer, CGGAATT-CCTACCAGCCGCGTTCTTGCATACGC; YaaE: 5Ј-primer, GGAA-TTCCATATGTTAACAATAGGTGTACTAGGAC, 3Ј-primer, CC-GCTCGAGCTATACAAGTGCCTTTTGCTTATATTCC or CCGC-TCGAGTACAAGTGCCTTTTGCTTATATTCC, i.e. with or without stop codon), using the isolated genomic DNA as template, and cloned into the NcoI/EcoRI (YaaD) and NdeI/XhoI (YaaE) restriction sites of pET21a or pET24b (Novagen), to give plasmids pET-BsYaaD, pETBsYaaE, and pET-BsYaaE-His6, respectively. Cloning into the vector in this way allows expression of the proteins in their native form and in the case of YaaE without and with a C-terminal hexahistidine affinity tag. Each expression construct was verified by sequence analysis after transformation into E. coli DH5␣ cells (Stratagene). Induction of expression was carried out in E. coli BL21(DE3) cells by addition of isopropyl-1-thio-D-galactopyranoside to a final concentration of 0.5 mM and growth at 37°C for 3 h after which the cells were harvested by centrifugation and subsequently stored at Ϫ80°C.
Purification of YaaD and YaaE-YaaD was isolated by a combination of anion exchange and hydrophobic interaction chromatography. Cell paste from 4 liters of culture medium (ϳ20 g) was resuspended in 50 ml of Buffer A (50 mM Tris-Cl, 10 mM NaCl, 0.4 mM dithiothreitol, 1.3 mM EDTA, 1.2 mM phenylmethylsulfonyl fluoride, 10% glycerol, pH 7.5). Lysozyme was added to a final concentration of 1 mg/ml, and after 20 min at 4°C the cells were further lysed by sonication. DNase I (0.1 mg/ml) was used to help clarify the resulting suspension, which was then centrifuged at 25,000 ϫ g for 30 min at 4°C. The supernatant was defined as the crude extract and loaded onto a DEAE-Sephacel column (2.5 ϫ 15 cm), freshly equilibrated in Buffer A. After extensive washing with Buffer A, bound protein was eluted using a linear gradient of 250 ml each of Buffer A and Buffer B (as for A except containing 300 mM NaCl) while collecting 7-ml fractions. The YaaD-containing fractions were pooled and dialyzed against Buffer A overnight. The dialysate was brought to 30% ammonium sulfate saturation and applied to a phenylSepharose column (2.5 ϫ 15 cm) freshly equilibrated in Buffer C (as for Buffer A but containing 0.75 M ammonium sulfate). After washing, bound protein was eluted with a linear gradient of 250 ml each of Buffer C and Buffer A. Fractions containing YaaD were pooled, concentrated, exchanged into 20 mM Tris-Cl, 10 mM NaCl, pH 7.5, and stored at Ϫ80°C until required. Native YaaE was isolated in exactly the same fashion as for YaaD with the following exception. Hydroxyapatite chromatography was substituted for the phenyl-Sepharose step. After DEAE-Sephacel chromatography, YaaE-containing fractions were dialyzed overnight in Buffer D (5 mM potassium phosphate, 0.4 mM dithiothreitol, 10% glycerol, pH 7.5). The dialysate was applied to a hydroxyapatite column (2.5 ϫ 18 cm) freshly equilibrated in the same buffer. After extensive washing bound protein was eluted with a linear gradient of 250 ml each of Buffer D and Buffer E (as for Buffer D but containing 150 mM potassium phosphate). Fractions containing YaaE were pooled, concentrated into 20 mM Tris-Cl, 10 mM NaCl, pH 7.5, and stored at Ϫ80°C until required for use. The hexahistidine-tagged YaaE was purified by Ni-NTA chromatography according to the protocol (protocol 11) supplied by the manufacturer (Qiagen). The isolated YaaD and YaaE were judged to have a purity of Ͼ95% as analyzed by SDS-PAGE using the buffer system described by Laemmli (30) (provided as supplemental data), and their identities were confirmed by N-terminal sequencing.
Coupled Enzyme Assay-YaaE activity was determined via a coupled reaction with glutamate dehydrogenase. In this assay, glutamine is hydrolyzed by YaaE to glutamate which is converted to ␣-ketoglutarate by glutamate dehydrogenase accompanied by the reduction of 3-acetylpyridine adenine dinucleotide (APAD), an analog of NAD ϩ that shifts the unfavorable equilibrium of the glutamate dehydrogenase reaction. Its reduction can be observed as an increase in the absorbance at 363 nm (⑀ APAD ϭ 8300 M Ϫ1 ⅐cm Ϫ1 ). Samples were assayed at 37°C in a total reaction volume of 300 l containing 50 mM Tris-Cl, pH 8.0, 0.5 mM APAD, 7 units of bovine glutamate dehydrogenase (assay buffer), and 10 mM glutamine. For determination of the kinetic constants, 4 M YaaD and 4 M YaaE were used. Protein concentrations were determined using Bradford reagent (Pierce) employing bovine serum albumin as a standard.
SCHEME 1
Determination of YaaD Enzymatic Activity-The activity of YaaD was monitored by UV-visible spectrophotometry where the appearance of a maximum at 414 nm indicated enzymatic formation of a Schiff's base, presumably formed by the generated reaction product and the primary amine of the Tris buffer (2-amino-2-(hydroxymethyl)-1,3-propanediol) used in the assay. Reactions were carried out in 50 mM Tris-Cl, pH 8.0, at 37°C containing 40 M of the isolated YaaD and/or YaaE and 0.5 mM of the substrates; either ribose 5-phosphate or ribulose 5-phosphate and either dihydroxyacetone phosphate or DL-glyceraldehyde 3-phosphate (1 mM). As a nitrogen source either 10 mM glutamine or 10 mM ammonium sulfate was added.
UV-visible Absorbance Spectrophotometry-All spectrophotometric measurements were recorded on a UVIKON XL double-beam spectrophotometer (Flowspek AG, Basel, Switzerland).
HPLC of the Reaction Product-For analysis of the reaction product by HPLC, samples were first deproteinated by ultrafiltration followed by methanol-chloroform precipitation. The deproteinated sample was then applied to a C18 reversed phase column (LiChroCART 250 -4, RP-18, 5 M, Merck) equilibrated in 0.1% trifluoroacetic acid using the Beckman System Gold apparatus. Comparison with commercially available standards was performed by employing isocratic elution (1 ml⅐min Ϫ1 for 10 min) followed by a gradient of 0 -50% acetonitrile. In the case where the reaction product was required on a preparative scale, the product from a total volume of 8 ml was deproteinized as above and isocratically eluted with 0.1% trifluoroacetic acid on a LiChroCART RP-18 column (Merck 250 -10, 5 M, flow rate 6 ml⅐min Ϫ1 ). Inactivation by Acivicin-The rate of inactivation of YaaE was determined by preincubation of equimolar concentrations of YaaD and YaaE (4 M) in assay buffer (as above) with varying concentrations of the inhibitor (1, 2, and 10 mM) at 37°C. At various time intervals, the glutaminase activity was measured by addition of 30 l of a 0.1 M glutamine stock solution to give a total reaction volume of 300 l. The time course of the fraction of catalytic activity remaining showed a pseudo-firstorder decay from which the rate constant k was obtained by a fit of the data to the exponential function (Equation 1) (31).
NMR Analysis-The
The plots of the pseudo-first-order rate constants versus the initial acivicin concentration yielded second-order rate constants for the inactivation of YaaE. For the demonstration of the inactivation of PLP synthesis, YaaD (40 M) and YaaE (40 M) were incubated with various amounts of acivicin (0.04 -5 mM) in 50 mM Tris-Cl, pH 8.0, at 37°C for 60 min; PLP formation was monitored at 414 nm in the presence of 0.5 mM ribose 5-phosphate, 0.5 mM dihydroxyacetone phosphate, and either 10 mM glutamine or ammonium sulfate.
Labeling YaaE with Acivicin-Time-and concentration-dependent modification of YaaE with acivicin was carried out at 37°C in 60 l of 10 mM ammonium hydrogen carbonate, pH 7.9, containing 40 M YaaD and 40 M YaaE. The reaction was started by addition of acivicin to a final concentration of 1 mM. 5-l aliquots were removed at various time points, and the reaction stopped by addition of 5 l of acetonitrile containing 0.4% trifluoroacetic acid (v/v). Samples were directly spotted onto a MALDI-plate and mixed with an equal volume of sinapic acid (10 mg/ml) dissolved in 50% acetonitrile/0.1% (v/v) trifluoroacetic acid. The samples were allowed to air dry. Spectra were acquired with a MALDI-TOF/TOF mass spectrometer (4700 Proteomics Analyzer, Applied Biosystems) in the positive ion mode. The percentage of labeling of YaaE with acivicin was calculated from the intensities of the peaks corresponding to the unmodified and modified protein. 
Identification of the Residue Labeled by Acivicin-To identify the site of acivicin modification, 60 M YaaE was incubated in the presence of 60 M YaaD with 5 mM acivicin in 50 mM Tris-Cl, pH 7.5, in a total reaction volume of 100 l for 15 min at 37°C. Labeled YaaE was separated from YaaD by size exclusion chromatography on a Superose 6 10/300 (Amersham Biosciences) gel-filtration column mounted on an Ä KTA Explorer system (Amersham Biosciences) in 50 mM Tris-Cl, pH 7.5, containing 150 mM NaCl. The injection volume was 100 l, and the flow rate was set to 0.5 ml/min. The fraction corresponding to YaaE was collected, concentrated using filter units (Centricon YM30, Millipore), and dialyzed for 24 h against 50 mM ammonium hydrogen carbonate. YaaE was subjected to protease digestion by addition of 1 g of trypsin and incubation for 24 h at 37°C. The digested protein was applied to an HPLC system (Ti-Series 1050, Hewlett-Packard) equipped with a C18 reversed phase column (Nucleosil 300 -5 C18, Macherey-Nagel), equilibrated in 0.05% trifluoroacetic acid (v/v). A gradient of 0 -60% acetonitrile/0.05% trifluoroacetic acid (v/v) at 0.5 ml/min was established over 45 min, held for 5 min, raised to 80% acetonitrile/0.05% trifluoroacetic acid (v/v) over 5 min, and then returned to the starting conditions over 15 min. The elution was monitored at 215 nm, and 0.5-ml fractions were collected. The fractions were dried in a SpeedVac concentrator and resuspended in 66% acetonitrile/0.1% trifluoroacetic acid (v/v) for analysis by MALDI-TOF/TOF-MS. A sample of 0.5 l was mixed with 0.5 l of 5 mg/ml ␣-cyano-4-hydroxycinnamic acid dissolved in 66% acetonitrile/0.1% trifluoroacetic acid (v/v) and directly spotted onto a MALDI-plate. For MS/MS, the peptide was selected and fragmented by collision-induced fragmentation using helium as the collision gas.
Native PAGE-Polyacrylamide gel electrophoresis was carried out in 12.5% gels using the system described by Laemmli (30) under nondenaturing conditions, i.e. in the absence of SDS and reducing agent at 4°C. YaaD (20 M) and YaaE (20 M) were incubated either separately or together in 50 mM Tris-Cl, pH 7.5. Acivicin when present was at a concentration of 1 mM. The samples were incubated for 15 min at 37°C in a total volume of 30 l prior to addition of 30 l of two times native PAGE sample loading buffer. Thirty picomoles of protein was loaded per lane.
Generation of Antiserum/Immunochemical Methods-An antibody against YaaE was raised and utilized at a dilution of 1:1000 essentially as described in (29) with the exception that in the present study PAGE analysis under non-denaturing conditions was carried out.
YaaE Pull-out Assay-Equimolar concentrations (20 M) of the isolated native YaaD and hexahistidine-tagged YaaE were preincubated in 20 mM Tris-Cl, pH 8.0, containing 10 mM NaCl (Buffer A) at 37°C for 15 min in a total volume of 50 l. The proteins were immobilized by adding 50 l of a 1:1 suspension of Ni-NTA equilibrated in the same buffer followed by incubation at 4°C for 90 min with gentle rotation. Protein bound to the matrix was washed two times with 1 ml of Buffer A followed by elution with the same buffer containing 150 mM imidazole and analyzed by SDS-PAGE.
RESULTS
Enzymatic Properties of YaaE-The isolation of native YaaE in its active form was demonstrated by employing a coupled glutaminase assay. Glutamate released during the course of the reaction facilitates the reduction of the NAD ϩ analog, 3-acetylpyridine adenine dinucleotide (APAD), in the presence of glutamate dehydrogenase and can be detected as an increase in the absorbance at 363 nm. Glutaminase activity of YaaE was only detected in the presence of its partner protein YaaD.
In the presence of either protein alone the rate of glutamine hydrolysis did not exceed the background autocatalytic rate. Thus, under the conditions employed here, glutaminase activity of YaaE alone is Յ0.5% of that in the presence of both proteins. A 1:1 stoichiometry of both proteins appeared to be optimal for activity. Varying the concentration of glutamine in the assay produced typical Michaelis-Menten kinetics, from which we could determine the catalytic constants, k cat and K m (7.60 Ϯ 0.01 min Ϫ1 and 0.99 Ϯ 0.01 mM, respectively). These results are provided as supplemental data.
Identification of YaaD Substrates-Based on labeling (12, 14, 25) and genetic studies in yeast (26) , potential substrates of YaaD were considered and tested for their ability to form vitamin B6 in the presence of YaaE and glutamine in 50 mM Tris-Cl, pH 8.0. Employing the pentulose sugar ribulose 5-phosphate and either of the triose sugars glyceraldehyde 3-phosphate or dihydroxyacetone phosphate, enzymatic activity could be observed by the appearance of an absorbance maximum at 414 nm. This absorbance is characteristic for pyridoxal 5Ј-phosphate forming a Schiff's base with the Tris buffer reagent (2-amino-2-(hydroxymethyl)-1,3-propanediol) used in the reaction. While this report was in preparation, the same observations were independently published by the group of T. Begley (27) who showed that, in addition, ribose 5-phosphate can serve as a substrate of YaaD. We have since been able to corroborate this result and have determined the steady-state kinetic constants of the reaction from initial rate measurements. Incubation of YaaD (40 M) and YaaE (40 M) in the presence of glutamine (10 mM), while systematically varying the concentration of either ribose 5-phosphate or DL-glyceraldehyde 3-phosphate, resulted in typical MichaelisMenten behavior (Fig. 1, A and B, respectively) 2ϩ had no effect on the observed rates. The non-phosphorylated carbohydrates, i.e. D-ribulose and D-glyceraldehyde, did not support any significant activity, implying that the phosphate ester moiety of the substrates is required for binding within the active site. In addition, when glutamine is used as the nitrogen source, the synthase reaction of YaaD is absolutely dependent on YaaE, as no reaction was observed in its absence. As for other glutamine amidotransferases, an external source of ammonium (e.g. ammonium sulfate) could substitute for glutamine and an equal catalytic rate was observed, but in contrast to glutamine, concentrations higher than 10 mM caused inhibition. Interestingly, when ammonium sulfate is used as the nitrogen source the reaction can take place in the absence of YaaE with either of the C3 carbohydrates and ribose 5-phosphate, but not ribulose 5-phosphate (Fig. 1C) . Somewhat surprisingly, it was also observed that the addition of the C5 or C3 YaaD substrates either alone or in combination did not enhance the glutaminase activity of YaaE (data not shown).
Identification of the YaaD Reaction Product-Enzyme activity of a histidine-tagged version of YaaD was recently shown by Burns et al. (27) . The reaction product was reported to be PLP, but proof in the form of a 1 H NMR spectrum did not support this statement. In particular, the characteristic aldehyde proton was omitted and moreover misassigned to the C6 proton at 7.45 ppm (27) . In our analysis, treatment of the reaction product with either sodium borohydride or sodium hydroxide resulted in shifts in the absorption maximum from 414 to 317 and 390 nm, respectively, that are characteristic of PLP under identical conditions ( Fig. 2A) . Comparison of the reaction product to commercially available standards (pyridoxine, pyridoxal, and PLP) by reversed-phase HPLC resulted in co-chromatography with authentic PLP (Fig. 2B) . To confirm the identity of the reaction product, a 600-MHz 1 H NMR spectrum was acquired in D 2 O (provided as supplemental data). The spectrum clearly indicates that pyridoxal 5Ј-phosphate was formed, which is A representative example is shown where synthesis in the presence of ribose 5-phosphate (0.5 mM), dihydroxyacetone phosphate (0.5 mM), and glutamine (10 mM) was monitored.
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present in equilibrium between the aldehyde and its hydrate (shown as supplemental data). The aldehyde shows a singlet at ␦ 10.45 (1 H, CHO), a singlet at ␦ 8.02 (1 H, H-6) , a doublet at ␦ 5.28 (2 H, J HP ϭ 6.96 Hz, CH 2 OP), and a singlet at ␦ 2.60 (3 H, CH 3 ), whereas the hydrate shows a singlet at ␦ 8. 18 (1 H, H-6) , a singlet at ␦ 6.51 (1 H, CH(OH) 2 ), a doublet at ␦ 5.10 (2 H, J HP ϭ 7.32 Hz, CH 2 OP), and a singlet at ␦ 2.62 (3 H, CH 3 ), which is identical to that of authentic PLP. In contrast to the spectrum provided by Burns et al. (27) , the functional aldehyde group, a characteristic of PLP, could be observed. An electrospray mass spectrum of the product revealed peaks of m/z 246.00 (C 8 H 9 NO 6 P Ϫ ) in the negative ion mode and of m/z 248.02 (C 8 H 11 NO 6 P ϩ ) in the positive ion mode, thereby matching theoretical values of m/z 246.02 and m/z 248.03, respectively. All of the data provided here confirm the identity of the reaction product as PLP. Acivicin Inhibition of Enzyme Activity-The glutaminase activity of YaaE was probed by examining its susceptibility to inactivation by the glutamine analog acivicin. Acivicin irreversibly inhibits glutaminases by covalent modification of an essential cysteine residue (19) (Scheme 2).
An example of the decrease in the ability of YaaE to hydrolyze glutamine, as a function of time upon preincubation with acivicin (5 mM), is shown in Fig. 3A . The effect of the acivicin concentration on the fraction of glutaminase activity remaining versus preincubation time is shown in Fig. 3B . In each case, the loss in catalytic activity appears as a pseudofirst order decay from which the rate constants for inactivation could be estimated as 1.35 Ϯ 0.05 min Ϫ1 , 0.54 Ϯ 0.03 min Ϫ1 , and 0.19 Ϯ 0.02 min Ϫ1 , for 10 mM, 5 mM, and 2 mM acivicin, respectively, by fitting to Equation 1 (31) . A plot of the first order rate constants for inactivation of glutaminase activity versus the acivicin concentration (data not shown) reveals that the second order rate constant for inactivation of YaaE is 147 Ϯ 11 M Ϫ1 ⅐min Ϫ1 . Because YaaD activity in the presence of glutamine is dependent on a functional YaaE, we also examined the effect of acivicin on PLP synthesis under these conditions. As expected, preincubation of YaaE with acivicin results in a complete inhibition of YaaD activity (Fig. 3C) .
Modification of YaaE by Acivicin-To prove the covalent modification of YaaE by acivicin, MALDI-TOF mass spectrometry was used to show the concomitant increase in the molecular mass of the protein.
The observed masses for unmodified and modified YaaE were 21,443.8 and 21,581.6 Da, respectively (Fig. 4, A and B) , which agree well with the predicted masses of 21,447 and 21,588 Da, respectively. Furthermore, analogous to the glutaminase activity, modification of YaaE by acivicin is absolutely dependent on the presence of YaaD in the reaction mixture (equimolar concentrations of each); no reaction was observed with acivicin and YaaE alone under the same conditions. The reaction with acivicin occurs in a time- (Fig. 4C) indicates that glutamine protects the enzyme from inactivation, making it likely that the inactivation event is due to the modification of an active site residue within the binding site for glutamine.
Identification of the Active Site Cysteine
Residue-To identify the modified active site residue of YaaE, a tryptic digestion was performed on protein that had been modified with 5 mM acivicin for 15 min at 37°C in the presence of an equimolar amount of YaaD. A direct analysis of the resulting peptides by MALDI-TOF mass spectrometry did not reveal any masses corresponding to an expected peptide plus a bound acivicin molecule (data not shown). It was necessary to first separate the peptides using RP-HPLC from which a comparison of the elution profiles of untreated (Fig. 5A ) and treated YaaE (Fig. 5B) revealed the appearance of a prominent new peak (*) in the acivicin treated sample. Prior to protease digestion and RP-HPLC, the sample was subjected to gel-filtration, which facilitated removal of YaaD, thereby reducing the complexity of the peptide elution profile. MALDI-TOF mass spectrometry of the RP-HPLC fraction containing the new peptide peak indicated the mass of an expected peptide, PMFGTCAGLIILAK (1398.2 Da) with an acivicin molecule bound (1576.8 Da). An MS-MS analysis of this peptide revealed that acivicin was covalently bound to the cysteine residue in this peptide corresponding to cysteine 79 in YaaE (Fig. 6) .
Evidence for a Transient Interaction of YaaD and YaaE-To test if acivicin had an effect on the interaction between YaaD and YaaE we performed "pull-out" assays with a hexahistidine-tagged version of YaaE and native YaaD. Preincubation of equimolar amounts of His-tagged YaaE and native YaaD in the absence of acivicin results in the co-elution of YaaD with YaaE by Ni-NTA chromatography (Fig. 7A, lane 2) . However, preincubation in the presence of acivicin results in no specific co-elution of YaaD with YaaE (Fig. 7A, lane 3) , when compared with the unspecific binding of YaaD alone (Fig. 7A, lane 1) . This indicates that acivicin-modified YaaE no longer associates with YaaD. To corroborate this finding a native PAGE analysis of the untagged form of YaaE under various conditions was performed. On its own, YaaD appears as a single clearly defined band close to the cathode (Fig. 7B, lane 1) , whereas YaaE alone appears as two bands of similar mobility close to the anode, a major intense band and a much less intense minor band of slightly higher mobility (Fig. 7B, lane 4) . In the presence of YaaE, the YaaD protein band shows a mobility shift toward the cathode with a concomitant decrease in the intensity of the YaaE bands, indicating an interaction of YaaE and YaaD (Fig. 7B, lane 2) . This is substantiated by immunodecoration of the YaaD band employing an antibody specific for YaaE (Fig. 7C, lane 2) . Addition of glutamine (10 mM) did not change the appearance of the protein bands (data not shown). However, in the presence of 1 mM acivicin (Fig. 7B, lane 3) , YaaE is observed as only a single intensely stained band, which corresponds to the higher mobility band of the two observed with YaaE alone (Fig. 7B, lane 4) , whereas YaaD (Fig. 7B, lane 3) has returned to the original mobility observed in the absence of YaaE (Fig. 7B, lane 1) . In addition, the absence of labeling of the YaaD band with the YaaE antibody clearly indicates that under these conditions YaaE was no longer bound to YaaD (Fig. 7C, lane 3) .
DISCUSSION
The recent discovery that the biosynthesis of vitamin B6, in the majority of organisms, occurs by a pathway distinct from the well studied one in E. coli (1, 16) has provided an impetus to re-examine the biochemistry and physiology of this essential nutrient. Studies have been spurred on by the additional revelation that the vitamin is a potent antioxidant equivalent to vitamins C and E (1), while the absence of the pathway in animals could make it a novel target for the development of antimicrobial and antiparasitic agents. However, validating the pathway as a novel drug target requires a detailed characterization of the proteins involved.
In this report we employed the recombinant B. subtilis proteins YaaD and YaaE (homologs of PDX1 and PDX2, respectively) for characteriza- tion studies. The isolation of active protein was confirmed by the ability of YaaE to catalyze the hydrolysis of glutamine, an activity that is dependent on YaaD, its partner protein. The specific activity (301 nmol⅐min Ϫ1 ⅐mg Ϫ1 ) is of the same order as that observed for the homologous yeast (480 nmol⅐min Ϫ1 ⅐mg Ϫ1 ) (23) and P. falciparum proteins (209 nmol⅐min Ϫ1 ⅐mg Ϫ1 ) (24) . However, there is typically a large variation in the amount of activity observed in the glutaminase family of proteins, depending on whether the acceptor domain and its substrates are present or not. Recently, Burns et al. (27) identified the substrates of YaaD and in vitro reconstitution of vitamin B6 biosynthesis was accomplished. Although our own independent studies confirm the work of Burns et al. (27) , in this study we additionally prove beyond doubt that the reaction product is pyridoxal 5Ј-phosphate. We have also shown that, as for other glutamine amidotransferases, the synthase reaction can take place in the absence of the glutaminase domain when an external source of ammonium is used as the nitrogen donor, but in this case YaaE is dispensable only when ribose 5-phosphate is used as the C5 carbohydrate. Intriguingly, and in contrast to what is generally observed for glutamine amidotransferases, the glutaminase domain must be present for the reaction to occur when ribulose 5-phosphate is used. The reason for this is unknown at present, but one could speculate that the pentulose isomerase activity of YaaD is reliant on YaaE. Depending on whether the enediolate intermediate or ribose 5-phosphate itself is the true substrate, the deprotonation and/or protonation of the C5 carbohydrate, which occurs during the isomerization reaction could be facilitated by YaaE. Although a mechanism for the newly identified pathway of PLP synthesis was proposed originally by Ian Spenser's group (12) and has since been modified by Burns et al. (27) , future work will concentrate on the detection of key intermediates to prove the mechanistic hypothesis. The finding that PLP, rather than pyridoxine 5Ј-phosphate as in the case of E. coli, is the direct product of the synthesis would make the new pathway of vitamin B6 biosynthesis a highly efficient one, given that only two enzymes are required to produce PLP from phosphorylated carbohydrates and glutamine. This is in contrast to the situation in organisms that use the E. coli type pathway where six enzymes (four of which are exclusive to that pathway) are necessary for the formation of the initial product, pyridoxine 5Ј-phosphate, which has then to undergo transformation by pyridoxine oxidase (PdxH) to form PLP (Scheme 1). The latter enzyme is classified as part of the salvage pathway and, with the exception of archaea and Gram-positive bacteria (including B. subtilis), appears to be found in most organisms for which complete genomic information is available (11) . It is also significant that, in the alternative pathway, the "chicken and egg" paradox that prevails in the E. coli type pathway does not exist, i.e. PLP is not required as a cofactor in its own synthesis.
As mentioned above, the activities observed within the glutaminase family of proteins can vary depending on whether the acceptor domain and its substrates are present or not (31) . For example, in the case of guanosine monophosphate synthase, no detectable glutaminase activity is observed unless the substrates of the acceptor domain are added (32) . On the other hand, the rate observed with imidazole glycerol phosphate synthase in the absence of the acceptor substrate is of the same order of magnitude as that observed here but increases 125-fold in its presence (33) . In the case of the glutaminase described here, although its activity appears to be dependent on the acceptor domain YaaD, the substrates of the latter do not accelerate the rate observed. To our knowledge, this is the first report of a situation in which the acceptor substrates do not show an allosteric enhancement effect on the associated glutaminase. Thus, it could be concluded that in the case of YaaE, interaction with YaaD alone is sufficient to fully induce the glutaminase activity. However, the PLP synthase activity observed here is sub-optimal and thus restricts a detailed analysis of the effect of the YaaD substrates on the rate of glutamine hydrolysis. Elucidation of the additional factor required will facilitate the quantitative analysis of the parameters affecting the glutaminase activity.
For the first time, we report here on the reaction of the chemotherapeutic agent acivicin with a glutaminase that is involved in vitamin B6 biosynthesis. The second order rate constant observed (147 Ϯ 11 M Ϫ1 ⅐min Ϫ1 ) for the inactivation of the glutaminase activity is remarkably similar to those observed for the glutaminase domain of other glutamine amidotransferases under equivalent conditions, e.g. 200 and 90 M Ϫ1 ⅐min Ϫ1 for S. cerevisiae carbamoyl phosphate synthetase and imidazole glycerol phosphate synthase, respectively (31) . As for the glutaminase activity of YaaE, its inhibition by acivicin is dependent on YaaD. In this study, a method for directly monitoring the irreversible covalent modification of YaaE by acivicin using mass spectrometry is described, which allowed the determination of rate constants independently of the glutaminase activity. This method produced a second order rate constant (139 Ϯ 15 M Ϫ1 ⅐min Ϫ1 ), which is almost identical to the equivalent rate constant observed employing the glutaminase activity assay. As with other glutaminases (31), glutamine protected the enzyme from inactivation. Use of RP-HPLC and tandem mass spectrometry allowed us to unambiguously identify cysteine 79 as the active site residue in YaaE, thus confirming the prediction of Bauer et al. (20) , which was based on structural homology. As was expected, acivicin abolished PLP synthesis when glutamine was used as the nitrogen source. Because both the activity and inhibition of YaaE are dependent on YaaD, it is most likely that upon binding of YaaD a conformational change is induced in YaaE, which opens up the active site and thus enables ligand accessibility, thereby regulating glutamine hydrolysis. Such a mechanism most likely prevents the fortuitous release of ammonia under physiological conditions. The proposed conformational change could involve movement of the loop that is known to reside above the active site (20) and/or result in movement of the active site cysteine priming it for nucleophilic attack. From numerous studies on glutaminases it is believed that the hydrolysis of glutamine proceeds through two tetrahedral adducts and a glutamyl thioester intermediate (34, 35) . In the currently favored mechanism, the carbonyl carbon of the glutamine side chain is attacked by the thiolate anion of the active site cysteine, yielding a tetrahedral adduct. The collapse of this structure is facilitated by protonation of the side-chain amine group by an active site histidine, thereby forming a thioester intermediate and ammonia. The ammonia departs, after which the thioester intermediate is cleaved, presumably by a water molecule that has been activated through its interaction with the active site histidine, resulting in release of glutamate (34, 35) . In the case of certain glutamine amidotransferases, e.g. carbamoyl phosphate synthetase, it has been possible through the use of substrate analogs and site-directed mutagenesis to define proposed intermediates, i.e. the Michaelis complex, the tetrahedral adducts, and the glutamyl thioester intermediate, from high resolution structures (34, 35) . A comparison with the structure of acivicin modified wild-type protein has led to the conclusion that the covalently bound acivicin mimics the conformation observed for both the tetrahedral and thioester intermediates in the active site (31) . Thus, acivicin modification provides a way of "locking" the protein in a state of glutamine hydrolysis, which may be characterized by the presence of the oxyanion hole (28) .
The analysis of YaaE by native-PAGE suggests that YaaE exists in an equilibrium between two different forms as exemplified by the two bands observed (Fig. 7B, lane 4) . However, acivicin-modified YaaE was only observed as the lower of the two bands seen with the unmodified protein. This could be evidence for the locking of YaaE in a particular state that might be characterized by an ordered active site. In light of this it is noteworthy that, in the currently available structure of YaaE, which is in the absence of ligands, the oxyanion hole is not in a structurally defined state that would be required for glutamine hydrolysis (20) . What is most interesting, and to our knowledge has not been reported for any glutaminase, is that acivicin-modified YaaE has a dramatically reduced affinity for the acceptor domain YaaD. The exact intermediate that the modified YaaE mimics in the reaction mechanism remains to be deciphered, but this state could reflect the situation in vivo after delivery of ammonia to YaaD.
To summarize, in agreement with the predictions from an amino acid sequence alignment (18) and the recently published structure (20) , cysteine 79 of YaaE was shown here to be the target of acivicin. Although the glutamine amidotransferase described here has many features in common with other members of this family, there are a number of key differences reported herein. Firstly, the acceptor domain YaaD appears to be sufficient to stimulate the hydrolytic turnover of glutamine in YaaE and no effect on the rate is observed upon addition of the substrates of YaaD. Secondly, as for other glutamine amidotransferases, ammonia can substitute for glutamine as the nitrogen donor in vitro, but the synthase reaction appears to be dependent on the glutaminase domain under certain conditions. Because glutamine is the nitrogen source under physiological conditions as revealed by labeling studies (9, 10) , it can be concluded that the PLP synthase activity of YaaD and the glutaminase activity of YaaE are totally dependent on the respective protein partner. A more detailed characterization of the interaction between YaaE and YaaD would greatly benefit from the three-dimensional structure of the protein complex, all of which is beyond the scope of this report but is work currently in progress. 
Supplemental

